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Quebec City, Quebec, CanadaObjectives To study the causes of and to develop a risk score for failure of transradial approach (TRA)
for percutaneous coronary intervention (PCI).
Background TRA-PCI failure has been reported in 5% to 10% of cases.
Methods TRA-PCI failure was categorized as primary (clinical reasons) or crossover failure. Multivariate
analysis was performed to determine independent predictors of TRA-PCI failure, and an integer risk
score was developed.
Results From January to June 2010, TRA-PCI was attempted in 1,609 (97.3%) consecutive patients,
whereas 45 (2.7%) had primary TRA-PCI failure. Crossover TRA-PCI failure occurred in 30 (1.8%)
patients. Causes of primary TRA-PCI failure included chronic radial artery occlusion (11%), previous
coronary artery bypass graft (27%), and cardiogenic shock (20%). Causes for crossover TRA-PCI failure
included: inadequate puncture in 17 patients (57%); radial artery spasm in 5 (17%); radial loop in 4
(13%); subclavian tortuosity in 2 (7%); and inadequate guide catheter support in 2 (7%) patients.
Female sex (odds ratio [OR]: 3.2; 95% conﬁdence interval [CI]: 1.95 to 5.26, p < 0.0001), previous
coronary artery bypass graft (OR: 6.1; 95% CI: 3.63 to 10.05, p < 0.0001), and cardiogenic shock (OR:
11.2; 95% CI: 2.78 to 41.2, p ¼ 0.0011) were independent predictors of TRA-PCI failure. Risk score values
from 0 to 7 predicted a TRA-PCI failure rate from 2% to 80%.
Conclusions In a high-volume radial center, 2.7% of patients undergoing PCI are excluded from initial
TRA on clinical grounds, whereas crossover to femoral approach is required in only 1.8% of the cases. A
new simple clinical risk score is developed to predict TRA-PCI failure. (J Am Coll Cardiol Intv 2013;
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1130Compared with transfemoral approach (TFA), transradial
approach (TRA) for percutaneous coronary interventions
(PCI) has been shown to signiﬁcantly decrease vascular
complications (1–3), promote early mobilization, shorten
hospital stay (4), and lower healthcare costs (5). Although
there are reports of increasing TRA-PCI adoption world-
wide (6), its penetration remains highly variable, particularly
in the United States (7). There are several reasons for this
underutilization that might include the possibly over-
emphasized technical difﬁculties with TRA and relatively
high failure and crossover rates. Existing reports on TRA-
PCI failure have been conﬁned to selected cohorts of
patients in centers with low- to moderate-volume TRA
practice (8). Moreover, considerable variability regarding
failure rates in these reports is present, and accurate clin-
ical risk stratiﬁcation of TRA-PCI failure is consequently
of clinical importance. Furthermore, the outcomes of pa-
tients with failed TRA-PCI have not been previously re-
ported. We therefore sought to describe the incidence,
mechanisms, and predictors of TRA-PCI failure in a high-Abbreviations
and Acronyms
CABG = coronary artery
bypass graft
CI = conﬁdence interval(s)
OR = odds ratio(s)
PCI = percutaneous coronary
intervention(s)
TFA = transfemoral approach
TIMI = Thrombolysis In
Myocardial Infarction
TRA = transradial approachvolume tertiary radial center
among all comers and to derive
a simple clinical scoring system
predictive of TRA-PCI failure.
We also evaluated whether radial
approach failure had an impact
on clinical outcomes.
Methods
Study population. The study
population consisted of all con-
secutive patients who underwent
PCI at Québec Heart-Lung In-stitute from January 2010 to June 2010, irrespective of the
indication. For the purpose of this study, detailed demo-
graphic, clinical, and procedural characteristics were
prospectively entered into a dedicated database. Recorded
data included: baseline characteristics; indication for PCI;
pre-procedural laboratory tests; access site (puncture
attempts, failure and success); procedural material; ﬂuoros-
copy time; contrast volume; details of coronary intervention;
and, if any, need and reason for access site crossover. All major
adverse clinical events covering the in-hospital phase were
recorded and analyzed. The study was performed in accor-
dance with the institutional review board guidelines, and all
patients signed an informed consent prior to diagnostic
angiography and PCI.
TRA-PCI technique. During the study period, operators
included 6 interventional fellowship trainees (low- to
intermediate-volume radial operators) as well as 12 inter-
ventional cardiologists (high-volume radial operators, with
a minimum case volume of 200 PCI procedures per annum
for more than 10 years).In accordance with our institutional protocol, patients
underwent assessment of radial artery patency and adequacy
of dual hand blood supply using an oximetry test prior to
procedure by the catheterization laboratory nurses as previ-
ously described (9). The right radial artery was the default
access, and the left radial artery was used in case of previous
coronary artery bypass graft (CABG) with a left internal
mammary artery graft, or if the right radial artery was clin-
ically occluded. The choice of initial and ﬁnal access site for
individual patients was left to the discretion of the operator.
Using a dedicated arm board, and with the patient’s wrist
slightly hyperextended, the right or left radial artery was
cannulated after administration of 2 to 3 ml of local anes-
thetic, with a short, beveled, 19-gauge bare needle or
18-gauge Cathlon needle (BD Insyte, Becton Dickinson
Infusion Therapy Systems Inc., Sandy, Utah), as previously
described (4,10). A soft 0.035-inch straight guidewire was
then advanced into the radial artery lumen, and a 10-cm 5-
to 6-F nonhydrophilic introducer sheath (Terumo Medical
Corporation, Elkton, Maryland) was placed into the radial
artery. Following sheath insertion, an intraradial spasmolytic
cocktail of 2.5 mg of verapamil was routinely administered.
In case of faint radial pulse, subcutaneous 200 mg of nitro-
glycerin was sometimes used at the time of local anesthesia
(11,12). Fluoroscopy or selective angiography of radial,
brachial, or subclavian artery was only performed if difﬁculty
was encountered in advancing the guidewire or catheters.
All patients were pre-treated with aspirin and thieno-
pyridines (minimum loading dose of 300 mg of clopidogrel
if <3 days of pre-treatment) prior to the procedure. After
sheath insertion, an initial bolus of 70 IU/kg of unfractio-
nated heparin was administered intravenously. In case of ad
hoc PCI, an additional bolus of 30 IU/kg of unfractionated
heparin was sometimes given prior to the ﬁrst balloon
inﬂation. Where deemed appropriate, the use of bivalirudin,
or administration of glycoprotein IIb/IIIa inhibitors was at
the discretion of the physician in charge of the case.
The radial sheath was removed in the operating room
immediately following completion of the procedure, and
hemostasis achieved by application of a locally designed
adjustable plastic bracelet (ComfortClose, Benrikal Services
Inc., Quebec City, Quebec, Canada), or Hemostop (Zoom
Co. Médic Inc., Quebec City, Quebec, Canada). Per pro-
tocol, the bracelet was loosened every 15 min until hemo-
stasis was achieved, usually within 2 h (13).
Deﬁnitions and study outcomes. TRA-PCI failure was
deﬁned as the inability to either start or complete the proce-
dure via TRA. Hence, TRA-PCI failure was categorized into
2 groups: primary TRA-PCI failure when TFA access was
chosen as initial access for any clinical reason (no radial
puncture attempted); or crossover TRA-PCI failure, due to
inability to complete the PCI procedure via TRA, requiring
access site crossover to TFA. The sequence of crossover to
either contralateral radial or directly to femoral was left to the
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1131operator’s discretion. If, however, after crossover to contra-
lateral radial, the procedure was successfully completed via
second TRA, then this was classiﬁed as TRA success. Radial
artery spasm was deﬁned as: 1) the inability to advance the
arterial sheath or to manipulate the catheters; or 2) spasm
resulting in patient discomfort requiring access site crossover.
Major adverse cardiac events were deﬁned as death,
myocardial infarction, or need for revascularization (surgical
or percutaneous). Bleeding was divided into access-site– or
non-access-site–related and classiﬁed according to TIMI
(Thrombolysis In Myocardial Infarction) deﬁnitions (14).
Vascular complications were classiﬁed as major if associated
with bleeding that resulted in a drop in hemoglobin of
>3 g/dl and/or the need for blood transfusion or vascular
surgical repair. Local hematomas at the radial site were graded
according to a speciﬁc scale as previously described (4).
Statistical analysis. Continuous variables are summarized as
mean  SD or median (interquartile range), and categorical
variables as absolute numbers and percentages. Statistical
comparisons were performed using Pearson test for cate-
gorical variables, whereas Kruskal-Wallis testing and analysis
of variance were used for continuous variables.
To determine independent predictors of TRA-PCI
failure, all 18 baseline demographic and clinical parameters
in Table 1 were pre-screened by univariate logistic regressionTable 1. Baseline Characteristics
All Patients
(N ¼ 1,654)
TRA-PCI Success
(n ¼ 1,579)
Age, yrs 66  12 66  12
Male 1,174 (71) 1,136 (72)
Height, cm 168  9 168  9
Weight, kg 80  17 80  17
Diabetes 443 (27) 417 (26)
Hypertension 1,125 (68) 1,067 (68)
Hypercholesterolemia 1,196 (72) 1,133 (72)
Smoking history 748 (45) 714 (45)
Creatinine, mmol/l 84 (72–98) 83 (72–98)
Previous radial access 573 (35) 537 (34)
Previous PCI 460 (28) 427 (27)
Previous CABG 218 (13) 186 (12)
Indication for PCI
Stable angina 339 (21) 325 (21)
Unstable angina 501 (30) 480 (30)
NSTEMI 421 (25) 405 (26)
STEMIdprimary PCI 178 (11) 170 (11)
STEMIdrescue PCI 176 (11) 168 (11)
Cardiogenic shock 13 (0.8) 8 (0.5)
Other 26 (2) 23 (1)
Values are mean  SD, n (%), or median (interquartile range). Baseline char
success represents radial access. Primary and crossover failures represent
CABG ¼ coronary artery bypass graft; NSTEMI ¼ non–ST-segment elevat
STEMI ¼ ST-segment elevation myocardial infarction; TRA ¼ transradial apanalysis. Subsequently, 8 univariate predictors of TRA-PCI
failure were subjected to multivariate logistic regression
analysis with stepwise, backward, and forward procedures
where potential predictors of TRA-PCI failure were entered
and retained in the model at p < 0.10. A probability value of
<0.05 was considered statistically signiﬁcant.
Derivation and validation of an integer risk score. Indepen-
dent predictors of TRA-PCI failure according to the
preceding model formed the basis of the clinical integer risk
score, and we attributed a weight to each variable on the basis
of the regression coefﬁcient. Each integer amount is
a rounding of the exact ﬁgure obtained from the logistic
model. The area under the receiver-operating characteristics
curve for the integer score was determined by calculating the
C-statistic in logistic regression analyses with TRA-PCI as
the dependent variable and the integer score as the inde-
pendent variable. The 95% conﬁdence limits of this C-
statistic were generated by bootstrapping techniques using
1,000 replications of this model. The model’s goodness of ﬁt
was evaluated using the Hosmer-Lemeshow method. The
total risk score for any individual patient was the summation
of the 3 independent variables present. All calculations and
statistical analyses were performed using JMP (version 9.0,
SAS Institute, Cary, North Carolina) and SAS (version 9.3,
SAS Institute).Primary Failure
(n ¼ 45)
Crossover Failure
(n ¼ 30) p Value
66  14 67  13 0.69
24 (53) 14 (47) 0.0003
166  10 165  9 0.047
76  16 79  20 0.28
14 (31) 12 (40) 0.20
34 (76) 24 (80) 0.19
40 (89) 23 (77) 0.035
22 (49) 12 (40) 0.75
93 (74–112) 89 (78–110) 0.040
23 (51) 13 (43) 0.036
22 (49) 11 (37) 0.0030
23 (51) 9 (30) <0.0001
7 (16) 7 (23) 0.66
11 (24) 10 (33) 0.65
8 (18) 8 (27) 0.48
7 (16) 1 (3) 0.25
5 (11) 3 (10) 0.99
4 (9) 1 (3) <0.0001
3 (7) 0 (0) 0.013
acteristics of study population are categorized by access site. TRA-PCI
femoral access.
ion myocardial infarction; PCI ¼ percutaneous coronary intervention;
proach.
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1132Results
A total of 1,654 patients underwent PCI during the study
period and were divided into 3 groups on the basis of the
success or failure of TRA-PCI (Fig. 1). In 1,609 (97.3% of
total) patients, TRA-PCI was attempted and successfully
completed in 1,579 (95.5%) via initial or contralateral TRA
(TRA-PCI success), whereas crossover to TFA was neces-
sary in 30 (1.8%) patients to complete the procedure
(crossover TRA-PCI failure). The remaining 45 (2.7%)
patients were deemed ineligible for TRA-PCI for clinical
reasons and underwent PCI via initial TFA (primary TRA-
PCI failure) (Fig. 1).
Baseline and clinical criteria are depicted in Table 1.
Mean age of overall population was 66  12 years; 71%
were men; 27% were diabetic; 35% had previous radial
access; 28% had previous PCI; and 13% had previous
CABG. There were statistically signiﬁcant differences
between the 3 groups in baseline characteristics, as both the
primary and crossover TRA-PCI failure groups, compared
with the TRA-success group, were more likely to be
women (47% and 53%, respectively, vs. 28%; p ¼ 0.0003)
and have a higher incidence of previous radial access (51%
and 43% vs. 34%, p ¼ 0.036), previous PCI (49% and 37%Figure 1. Access Site Flow Chart for Study Population
Flow chart showing sequence of access site selection and need for access site crosso
artery; LRA ¼ left radial artery; PCI ¼ percutaneous coronary intervention; RFA ¼ righ
transradial approach; UA ¼ Ulnar artery.vs. 27%, p ¼ 0.003), and previous CABG (51% and 30%
vs. 12%, p < 0.0001). Furthermore, although procedural
indications were fairly similar across groups, both primary
and crossover TRA-PCI failure groups, compared with the
TRA-PCI success group, had a higher incidence of
cardiogenic shock at presentation (9% and 3% respectively,
vs. 0.5%, p < 0.0001). The left radial approach was more
commonly used as initial access in the TRA-PCI crossover
failure group (23% vs. 10%, p < 0.0001) than in the TRA-
PCI success group. Both TRA-PCI failure groups more
often underwent left main stem and graft interventions
and were more likely to receive bivalirudin as an antico-
agulant (Table 2).
In both the primary and crossover TRA-PCI failure
groups, ﬂuoroscopy time was signiﬁcantly longer than it was
for the TRA-PCI success group (15 and 19 min, respec-
tively, vs. 12 min, p ¼ 0.0015). The overall angiographic
success was 96.4%; however, this was signiﬁcantly lower in
the crossover TRA-PCI failure group than in the success
group (83% vs. 97%, p ¼ 0.0002).
Post-PCI outcomes. There was a higher incidence of major
adverse cardiovascular events in both the primary and
crossover TRA-PCI failure groups than in the TRA-PCI
success group (13% and 3.3% vs. 2%, p < 0.0001), higherver. Primary and crossover TRA-PCI failure are shown in red. LFA ¼ left femoral
t femoral artery; RRA ¼ right radial artery; TFA ¼ transfemoral approach; TRA ¼
Table 2. Procedural Characteristics
All Patients
(N ¼ 1,654)
TRA-PCI Success
(n ¼ 1,579)
Primary Failure
(n ¼ 45)
Crossover Failure
(n ¼ 30)
p
Value
Oximetry test <0.0001
A 50 (3) 48 (3) 1 (4) 1 (4)
B 1,427 (91) 1,384 (91) 18 (78) 25 (93)
C 67 (4) 67 (4) 0 (0) 0 (0)
D 19 (1) 14 (1) 4 (17) 1 (4)
Not performed/Allen 91 66 22 3
First access <0.0001
RRA 1,440 (87) 1,418 (90) d 22 (73)
LRA 164 (10) 157 (10) d 7 (23)
RUA 5 (0.3) 4 (0.3) d 1 (3)
FA 45 (3) d 45 (100) d
Sheath 0.0002
5-F 406 (25) 393 (25) 6 (13) 7 (23)
6-F 1,227 (74) 1,169 (74) 36 (80) 22 (73)
7-F 15 (1) 11 (1) 3 (7) 1 (3)
Procedure anticoagulant
UFH 1,413 (86) 1,357 (86) 30 (67) 26 (87) 0.0013
Bivalirudin 100 (6) 89 (6) 8 (18) 3 (10) 0.0025
GPI 287 (18) 277 (18) 6 (13) 4 (13) 0.61
Treated vessel
LMS 86 (5) 76 (5) 9 (20) 1 (3) <0.0001
LAD 707 (43) 683 (43) 13 (29) 11 (37) 0.12
LCX 455 (28) 432 (27) 15 (33) 8 (27) 0.68
Intermediate 35 (2) 34 (2) 0 (0) 1 (3) 0.55
RCA 651 (39) 622 (39) 17 (38) 12 (40) 0.97
Graft 78 (5) 70 (4) 5 (11) 3 (10) 0.045
Vessels treated per patient 0.68
1 1,322 (80) 1,263 (80) 34 (76) 25 (83)
2 283 (17) 271 (17) 8 (18) 4 (13)
3 34 (2) 30 (2) 3 (7) 1 (3)
4 3 (0.2) 3 (0.2) 0 (0) 0 (0)
Stents per procedure 1.7  1 1.7  1 1.9  1.5 1.7  1.5 0.411
Guiding catheter per procedure 1.1  0.4 1.1  0.4 1.1  0.5 1.3  0.7 0.052
Contrast volume, ml 182  72 181  72 191  61 201  66 0.23
Fluoroscopy time, min 12 (8, 19) 12 (8, 18) 15 (9, 22) 19 (11, 33) 0.0015
Angiographic success 1,595 (96.4) 1,525 (97) 45 (100) 25 (83) 0.0002
Values are mean  SD, n (%), or median (interquartile range). Dashes indicate that data was not observed.
FA ¼ femoral artery; GPI ¼ glycoprotein IIB/IIIa inhibitor; LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex; LMS ¼ left main stem; LRA ¼
left radial artery; RRA ¼ right radial artery; RCA ¼ right coronary artery; RUA ¼ right ulnar artery; UFH ¼ unfractionated heparin; other abbreviations as
in Table 1.
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1133in-hospital mortality (13% and 3.3% vs. 1%, p < 0.0001),
and signiﬁcantly higher need for blood transfusion (6.2%
and 3.3% vs. 0.3%, p < 0.0001). Similarly, both TRA-PCI
failure groups suffered signiﬁcantly more bleeding and access
site vascular complications than did the TRA-PCI success
group (radial access site) (9% and 10%, respectively, vs.
1.3%, p < 0.0001) (Table 3).
Causes and predictors of TRA-PCI failure. Common reasons
for primary TRA-PCI failure (n ¼ 45) included: radial
artery occlusion (11%), previous CABG with bilateral
mammary grafts or operator’s preference (27%), andpresentation in cardiogenic shock (20%). In contrast,
crossover TRA-PCI (n ¼ 30) was predominantly due to
inadequate radial arterial puncture (57%). Other mecha-
nisms included signiﬁcant radial artery spasm in 5 patients
(17%), radial loop or tortuosity in 4 (13%), subclavian
tortuosity in 2 (7%), and inadequate guide catheter support
in 2 (7%) (Table 4).
On multivariate analysis, female sex (odds ratio [OR]: 3.2;
95% conﬁdence interval [CI]: 1.95 to 5.26, p < 0.0001),
previous CABG (OR: 6.1; 95% CI: 3.63 to 10.05, p <
0.0001), and cardiogenic shock at presentation (OR: 11.2;
Table 3. In-Hospital Clinical Outcomes
All Patients
(N ¼ 1,654)
TRA-PCI Success
(n ¼ 1,579)
Primary Failure
(n ¼ 45)
Crossover Failure
(n ¼ 30) p Value
MACE 33 (2) 26 (2) 6 (13) 1 (3) <0.0001
Clinical outcomes
CABG 6 (0.4) 5 (0.3) 1 (2) 0 (0) 0.11
TVR-PCI 5 (0.3) 5 (0.3) 0 (0) 0 (0) 0.89
In-hospital death 23 (1.4) 16 (1) 6 (13) 1 (3) <0.0001
Stroke 3 (0.2) 3 (0.2) 0 (0) 0 (0) 0.93
Transfusion 9 (0.5) 5 (0.3) 3 (7) 1 (3) <0.0001
Any bleeding or vascular complication 28 (1.7) 21 (1.3) 4 (9) 3 (10) <0.0001
Non–access site bleeding
Genitourinary 1 (0.1) 1 (0.1) 0 (0) 0 (0) 0.98
GI bleed 1 (0.1) 1 (0.1) 0 (0) 0 (0) 0.98
Intracranial 2 (0.1) 2 (0.1) 0 (0) 0 (0) 0.95
Intraocular 0 (0) 0 (0) 0 (0) 0 (0) d
Retroperitoneal 4 (0.2) 1 (0.1) 3 (7) 0 (0) <0.0001
Access site complications
Hematoma 14 (0.9) 9 (0.6) 2 (4) 3 (10) <0.0001
Vascular surgery 0 (0) 0 (0) 0 (0) (0) d
Values are n (%). Bold values are statistically signiﬁcant. Dashes indicate that calculations were not applicable. In-hospital clinical outcomes are
categorized as per access site. TRA-PCI success represents radial access. Primary and crossover failure groups represent femoral site. MACE
includes death, myocardial infarction, and surgical or percutaneous revascularization.
GI ¼ gastrointestinal; MACE ¼ major adverse cardiac events; TVR ¼ target vessel revascularization; other abbreviations as in Table 1.
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113495% CI: 2.78 to 41.2, p ¼ 0.0011) were independent
predictors of TRA-PCI failure (Table 5). The C-index for
our predictive model of TRA-PCI failure was 0.76 indi-
cating good predictive ability.
Risk score of TRA-PCI failure. Based on the regression coef-
ﬁcients, an integer score was assigned to each of theTable 4. Causes of PCI Failure in Descending Order
Reason n (%)
Primary failuredprimary TFA, n ¼ 45
Cardiogenic shock 9 (20)
Previous CABGdoperator preference 8 (18)
Previous TRA-PCI failure 6 (13)
Radial artery occlusion 5 (11)
Previous CABGdbilateral mammary grafts 4 (9)
Previous CABG with LIMAdLRA harvested for conduit 2 (4)
Need to preserve RA as future conduitdyoung patient
16 years of age
1 (2)
Fixed ﬂexion deformity of forearm 1 (2)
Takayasu arteritis 1 (2)
Undetermined 8 (18)
Crossover failure (from TRA to TFA), n ¼ 30
Inadequate puncture 17 (57)
Radial spasm 5 (17)
Radial loop/tortuosity 4 (13)
Subclavian tortuosity 2 (7)
Inadequate guiding catheter support 2 (7)
LIMA ¼ left internal mammary artery; RA ¼ radial artery; TFA ¼ transfemoral approach; other
abbreviations as in Tables 1 and 2.multivariate predictors (female sex ¼ 1, previous CABG ¼
2, and cardiogenic shock ¼ 3), resulting in a possible clinical
risk score of TRA-PCI failure ranging from 0 to 7 (Table 6).
The incidence of observed TRA-PCI failure increased from
2% to 50% (Table 6). The predicted TRA-PCI failure
according to the risk score is depicted in Figure 2. Internal
validation with bootstrapping provided a C-statistic of
0.7587 (95% CI: 0.7568 to 0.7605). The model provided
good calibration as indicated by the nonsigniﬁcant Hosmer-
Lemeshow goodness of ﬁt (p ¼ 0.65).
Discussion
The main ﬁndings from this study are as follows. 1) In a
setting that promotes radial approach as default access site,
TRA-PCI can be successfully performed in >95% of all
comers, with very low primary and crossover failure rates. 2)
A novel simple clinical risk score can predict TRA-PCI
failure in 2% to 80% of cases. 3) Patients who undergo
TFA-PCI after primary or crossover radial approach failures
remain at higher risk of peri-procedural complications.
Despite the previously demonstrated advantages of TRA
for PCI, widespread adoption has not yet occurred. This is
probably multifactorial, due to known technical challenges
and steeper learning curve of TRA practice (15) and higher
failure rates requiring access site crossover that have previ-
ously been reported (1,8,16). This is also compounded by
concerns on higher radiation exposure and longer procedure
times (17).
Table 5. Multivariable Predictors of TRA-PCI Failure and Risk Score
Variable Model Coefﬁcient Model Coefﬁcient Rounded Clinical Risk Score Standard Error Chi-Square OR 95% CI p Value
Female 1.1599 1 1 0.2526 21.08 3.2 1.95–5.26 <0.0001
Previous CABG 1.8018 2 2 0.2590 48.36 6.1 3.63–10.05 <0.0001
Cardiogenic shock 2.4135 3 3 0.6780 12.67 11.2 2.78–41.2 0.0011
Clinical risk score assigned to each of the 3 variables represents model coefﬁcient (rounded to whole unit).
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1.
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1135In a large meta-analysis of randomized trials of radial
versus femoral access, Jolly et al. (1) demonstrated a signiﬁ-
cantly higher rate of access site crossover with radial access
(5.9%). Compared with TFA, TRA was associated with
a 3-fold increase in access site crossover (OR: 2.96; 95% CI:
2.02 to 4.35) (1). In a study of 2,100 patients undergoing
TRA-PCI over a 4-year period, representing only 38% of
total PCI volume, Dehghani et al. (8) showed a TRA-PCI
crossover failure rate of 4.7%, where low- to intermediate-
volume operators performed TRA-PCI in selected patients.
In a series of 10,676 patients undergoing TRA-PCI,
Burzotta et al. (16) reported an access site crossover of 4.9%.
In the ACCESS (A Randomized Comparison of Percuta-
neous Transluminal Coronary Angioplasty by the Radial,
Brachial and Femoral Approaches) study, Kiemeniej et al.
(18) showed that the major cause of TRA-PCI crossover
failure was the inability to obtain puncture and radial artery
spasm. In the TRAP-AMI (Transradial Primary Percuta-
neous Coronary Intervention in Acute Myocardial Infarc-
tion) study, Gellen et al. (19) studied TRA-PCI failure in
446 patients presenting with ST-segment elevation
myocardial infarction without cardiogenic shock. Primary
TRA-PCI failure was 4.1% and crossover TRA-PCI failure
was 4.7%. In a large randomized study comparing radial and
femoral approach in primary PCI, Romagnoli et al. (20)
recently showed an almost 10% of crossover in the radial
group. Hence, TRA-PCI failure rates remained higher in
high-risk clinical scenarios and complex procedures.Table 6. Observed Versus Predicted TRA-PCI Failure
Female
Prior
CABG
Cardiogenic
Shock Score* Patients
0 0 0 0 996
1 0 0 1 433
0 1 0 2 167
0 0 1 3 7
1 1 0 4 44
1 0 1 5 d
0 1 1 6 4
1 1 1 7 2
Values are number of instances unless otherwise indicated. Dashes indicate d
variables in any given combination (female sex, Previous CABG, cardiogenic sho
scores as 2; cardiogenic shock scores as 3. The score is the sum of these valu
Abbreviations as in Tables 1 and 5.Our study represents experience from a high-volume
academic tertiary center where TRA has been the default
access for 20 years. In contrast to available literature, our
unselected cohort included a signiﬁcant proportion of
patients undergoing TRA-PCI for high-risk clinical
scenarios and complex procedures. Despite this, our primary
and crossover TRA-PCI failure rates remained very low.
The principal cause of crossover TRA-PCI failure in the
current study was the inability to gain radial arterial access
(inadequate puncture), constituting 57% of total failures,
often in patients with previous radial access and clinically
very weak or absent radial pulse. Mechanical injury and shear
stress associated with sheath insertion induces an inﬂam-
matory process that may lead to intimal hyperplasia (21), in
addition to local thrombus formation (22). Intimal thick-
ening is observed more commonly in association with
repeated radial access (22). These changes could ultimately
lead to chronic radial artery occlusion and limit future use of
radial access. A recent international survey suggested that
most radial operators do not routinely check radial artery
patency following transradial catheterization (6). This also
emphasizes that signiﬁcant efforts should be exerted to
prevent and treat acute radial artery occlusion, as a number
of patients will require several procedures (23).
Furthermore, although micropuncture techniques, using
smaller gauge needles and 0.021-inch wire, are used by many
centers other than our own, there is currently no tangible
evidence that they are associated with a higher rate of successfulObserved
TRA-PCI Failure Observed %
Predicted
(95% CI) %
15 1.5 1.8 (1.2–2.7)
25 5.8 5.5 (3.9–7.9)
19 11.4 10.0 (6.7–14.7)
3 42.9 17.0 (5.1–43.6)
11 25.0 26.1 (17.6–37)
d d 39.5 (14.2–72.1)
1 25.0 55.4 (25.1–82.1)
1 50.0 79.8 (49.6–94.1)
ata were not observed. *Total score represent the summation of 3
ck). According to model coefﬁcient, female scores as 1; previous CABG
es. When more than 1 variable is observed, add 1 to the score.
Figure 2. TRA-PCI Failure According to Clinical Risk Score
Novel risk score based on 3 independent predictors of TRA-PCI failure (female
sex, previous coronary artery bypass graft, presentation in cardiogenic shock).
Total score ranges from 0 to 7. Abbreviations as in Figure 1.
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1136radial puncture. We therefore do not think our institutional
practice with 18- or 19-gauge needle and 0.035-inch wire has
inﬂuenced the incidence of inadequate puncture.
Our study also shows that, once radial access has been
obtained, the incidence of TRA-PCI failure rate was indeed
very small, mostly due to radial or subclavian tortuosity and/
or radial spasm. Anatomical variations of the upper limb
arterial system are relatively common and occur in 10% to
15% of cases (24). In the presence of signiﬁcant tortuosity,
these anomalies are a signiﬁcant cause of procedural failure
(25). Although some of these challenges can be overcome
with special techniques (26), signiﬁcant radial loops can
result in severe spasm and patient discomfort, necessitating
access site crossover.
In the present study, female sex, previous CABG, and
cardiogenic shock at presentation were independent
predictors of TRA-PCI failure. Those factors were present
more often in both the primary and crossover TRA-PCI
failure groups. The radial artery diameter is usually 2.5 to
3.0 mm at the level of the wrist, however, this is smaller in
women (27). Moreover, female sex, diabetes, and low body
mass index are independent predictors of radial artery
spasm (28), which in turn may contribute to TRA-PCI
failure. Similar to previous studies, we also identiﬁed
previous CABG as an independent predictor of TRA-PCI
failure and need to access site crossover (8). This is likely
due to a combination of factors, including advanced
atherosclerotic disease associated with vascular risk factors,
and potential anatomical and technical challenges in these
cases, such as inadequate selective graft cannulation, orpoor guide catheter support for graft interventions. In
addition, some operators may have a lower threshold for
choice of, or crossover to, TFA for graft imaging. There-
fore, the “previous CABG” risk of TRA-PCI failure may
be modiﬁable to some extent, depending on the operator’s
preference and skill. We also identiﬁed cardiogenic shock
as an independent predictor of TRA-PCI failure. Although
TRA is possible in w50% of patients with cardiogenic
shock (29), weak or absent radial pulses in such patients
represent a major challenge to obtain swift arterial access,
resulting in choice of primary TFA access (primary TRA-
PCI failure) (29).
Finally, we observed more ischemic and bleeding
complications in the primary and crossover TRA-PCI
failure groups. This ﬁnding is not unexpected as those
patients were particularly at high risk. This should further
emphasize that every effort and teamwork should be maxi-
mized so that the large majority of patients can undergo
TRA-PCI. Conversely, using our risk score may help
physicians and staff to pay particular attention to prevent
and manage peri-procedural complications.
Study limitations. This is an observational study with limi-
tations inherent to such a design. Our institution is a tertiary
care academic center, where fellows and residents at various
stages of training were involved in many procedures.
Although there is a system in place where experienced staff
take over from trainees in cases of difﬁcult puncture or
when problems arise, this information is not systematically
collected. Hence, it was not possible to analyze whether
operator experience played a role in failure rate. Given the
retrospective nature, we were not able to ascertain speciﬁc
reasons for primary TRA-PCI failure in all patients.
Endpoint of total TRA-PCI failure was pool of primary and
crossover failure for the purpose of this score. Although
reasons and predictors of primary and crossover failure are
different, they both lead to the same result: the use of TFA.
Given our high-volume experience with TRA and low
failure rate, our results may only be generalizable to centers
in which radial approach is the default access site.Conclusions
In a default radial center, 2.7% of all comers undergoing PCI
were excluded from initial TRA on pure clinical grounds.
Crossover to femoral approach was required in only 1.8% of
the cases. Female sex, previous CABG, and cardiogenic
shock were independent predictors of TRA-PCI failure. A
novel simple clinical risk score was developed to stratify
patients, and it can predict radial approach failure rates
between 2% and 80% in contemporary PCI practice.Acknowledgment
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